Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Graft Dysfunction”

54 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 54 results

Not applicableStudy completedNCT01887171
What this trial is testing

Evaluation of Preimplantation Portal Vein and Hepatic Artery Flushing With Tacrolimus

Who this might be right for
Early Allograft DysfunctionIschemic Reperfusion InjuryLiver Transplantation+1 more
Republican Scientific and Practical Center for Organ and Tissue Transplantation 86
Not applicableUnknownNCT02451046
What this trial is testing

Usefulness of Alpha-GST in Liver Transplantation

Who this might be right for
Evidence of Liver Transplantation
Beaujon Hospital 100
Not applicableStudy completedNCT00857844
What this trial is testing

Genetic Predisposition-Chronic Nephrotoxicity From CI-Liver Transplant Recipients-Potential Correlation-Urinary Biomarkers

Who this might be right for
Complication of Transplanted Liver
Northwestern University 207
Not applicableLooking for participantsNCT07685353
What this trial is testing

Influence of Donor and Recipient Genetic Polymorphisms on Graft Steatosis After Liver Transplant

Who this might be right for
Chronic Liver Disease and Cirrhosis
Institute of Liver and Biliary Sciences, India 50
Not applicableEnrolling By InvitationNCT06890234
What this trial is testing

Tissue Microdialysis Monitoring of Liver Grafts

Who this might be right for
Liver TransplantationLiver Graft DysfunctionTissue Metabolism
University Medical Centre Ljubljana 25
Early research (Phase 1)UnknownNCT05195125
What this trial is testing

Use of Direct Peritoneal Resuscitation in High-risk Liver Transplant Recipients

Who this might be right for
End Stage Liver DIseaseObesityAcute Kidney Injury
University of Colorado, Denver 15
Post-approval studies (Phase 4)Active Not RecruitingNCT05031026
What this trial is testing

Dexmedetomidine to Prevent Hepatic Ischemia-reperfusion Injury-induced Glycocalyx Degradation and Early Allograft Dysfunction in Liver Transplantation

Who this might be right for
Liver Transplant; Complications
Assiut University 60
Post-approval studies (Phase 4)Looking for participantsNCT07718126
What this trial is testing

Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)

Who this might be right for
Metabolic Dysfunction-Associated SteatohepatitisHepatic SteatosisLiving Liver Donors
West China Hospital 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06950398
What this trial is testing

Normothermic Oxygenated Perfusion (NMP) Viability Testing Before Transplantation of Discarded Livers

Who this might be right for
Organ TransplantationLiver DysfunctionLiver Diseases
Rennes University Hospital 99
Not applicableUnknownNCT02695979
What this trial is testing

Changes of Macrophage Migration Inhibitory Factor During Orthotopic Liver Transplantation

Who this might be right for
Evidence of Liver Transplantation
Medical University of Vienna 100
Not applicableUnknownNCT04324255
What this trial is testing

Von Willebrand Factor and Protein C Ratio in Graft Function After Liver Transplant

Who this might be right for
Liver Transplant; Complications
Asan Medical Center 1,199
Not applicableUnknownNCT02423941
What this trial is testing

Retrograde rEperfusion in Dbd Donor LIver Transplantation

Who this might be right for
Liver TransplantationReperfusionDelayed Graft Function
Republican Scientific and Practical Center for Organ and Tissue Transplantation 90
Not applicableNot Yet RecruitingNCT07658794
What this trial is testing

Intraoperative Assessment of Microcirculatory Function Using Vascular Occlusion Test During Liver Transplantation

Who this might be right for
Liver CirrhosisEarly Allograft Dysfunction
Ippokrateio General Hospital of Thessaloniki 50
Not applicableStudy completedNCT03448679
What this trial is testing

Albumin, COP and Endothelial Damage in Patients With ESLD Undergoing OLT

Who this might be right for
Transplant-Related Disorder
Medical University of Vienna 50
Not applicableLooking for participantsNCT05428267
What this trial is testing

Sexual Dysfunction in Cirrhosis

Who this might be right for
Sexual Dysfunction in Patients With Cirrhosis Awaiting Liver Transplantation
Assistance Publique - Hôpitaux de Paris 150
Not applicableUnknownNCT01781195
What this trial is testing

Delayed CNI-based Immunosuppression With Advagraf After MELD-based Liver Transplantation

Who this might be right for
Liver Graft Dysfunction
Heidelberg University 50
Not applicableEnrolling By InvitationNCT05082077
What this trial is testing

Global Utilization And Registry Database for Improved preservAtion of doNor Livers

Who this might be right for
Liver DiseasesLiver DysfunctionLiver Transplant Disorder+1 more
Paragonix Technologies 2,000
Post-approval studies (Phase 4)Study completedNCT02123108
What this trial is testing

Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver Transplantation

Who this might be right for
Liver Transplantation
University of California, Los Angeles 59
Testing effectiveness (Phase 2)Looking for participantsNCT07335601
What this trial is testing

Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH

Who this might be right for
MASH - Metabolic Dysfunction-Associated Steatohepatitis
Madrigal Pharmaceuticals, Inc. 120
Early research (Phase 1)Looking for participantsNCT07600788
What this trial is testing

A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.

Who this might be right for
Chronic Hepatitis B
Ausper Biopharma Co., Ltd. 32
Next Page